Pharmaceuticals in the environment: EC defines actions to address risks and challenges
The European Commission yesterday adopted a Communication outlining a set of actions addressing the multifaceted challenges that the release of pharmaceuticals poses to the environment.
The "Strategic Approach to Pharmaceuticals in the Environment" that the Commission presented yesterday, identifies six action areas concerning all stages of the pharmaceutical life cycle, where improvements can be made. The text addresses pharmaceuticals for human as well as for veterinary use. The areas cover all stages of the lifecycle of pharmaceuticals, from design and production to disposal and waste management, in line with the principles of the staff working document of the Commission on Sustainable Products in a Circular Economy. The six areas identified include actions to raise awareness and promote prudent use, improve training and risk assessment, gather monitoring data, incentivise “green design”, reduce emissions from manufacturing, reduce waste and improve wastewater treatment.
Karmenu Vella, Commissioner for Environment, Maritime Affairs and Fisheries yesterdaysaid:
“Most of us have had reason to take some form of medicine in our lives, and we are fortunate that we can be helped in this way. Pharmaceuticals are also essential for ensuring animal health. Many of us are however not aware that some of what is consumed ends up in the environment having an effect on wildlife such as the fish in our rivers. We must reduce the entry of pharmaceuticals into our rivers and soils for our own benefit and in order to protect the wildlife and the environment.”
Vytenis Andriukaitis, Commissioner for Health and Food Safety added:
“It is essential that medicines are safe and effective for our health, however we should be aware of the environmental impact they may have. Drug-resistant bacteria is one of the major health threats world-wide, therefore in our fight against antimicrobial resistance, everyone benefits not only from the prudent use of medicines but also from a well thought-through production and disposing system. It is time for us collectively to draw attention to the risks of the antimicrobials for the environment. . This Communication identifies areas where action is needed and serves us as a stepping stone for our future discussions.”
Pharmaceuticals discarded in the environment have been shown to pose a risk to fish or other wildlife, for example by affecting their ability to reproduce, by altering their behaviour in ways jeopardising their survival, or through direct toxic effects. In addition, incorrectly disposed medicinesmay contribute to the serious problem of antimicrobial resistance. Increased awareness has prompted further investigation, as well as calls and proposals for action to reduce emissions to the environment, in particular to water but also to soil.
Yesterday's Communication places an emphasis on sharing good practices, on cooperating at international level, and on improving understanding of the risks. This is crucial in the context of addressing antimicrobial resistance, a problem that is growing at global level. Several actions in the strategic approach are intended to contribute to the objectives of the European One-Health Action Plan against Antimicrobial Resistance (AMR). The Action Plan stresses the need for a One-Health approach taking account of the interconnections between human and animal health and the environment.
The Commission will follow up the actions set in the Communication, and invites Member States and other stakeholders to take action as well.
Pharmaceuticals are found in surface and groundwater across Europe that is used for irrigation and drinking water production and that is essential for wildlife. Awareness has grown in recent years of the possible risks from pharmaceuticals in the environment, but so far the knowledge and active policy for reducing the risks are still limited to only parts of the EU. The aim of the "Strategic Approach to Pharmaceuticals in the Environment" which was presented yesterday is to draw attention to those risks.
In 2013 the EU adopted legislation requiring the Commission to develop a strategic approach to pharmaceuticals in the environment, including proposals for measures, where appropriate, to address the possible impacts. The Strategic Approach has been developed taking into account information gathered through two scientific studies, as well as other information gathered from EU Member States, other stakeholders and research sources. The second study included an analysis of the results of a public and targeted stakeholder consultation on options for possible inclusion in the approach.
For more information
- Enrico BRIVIO (+32 2 295 61 72)
- Anca PADURARU (+ 32 2 299 12 69)
- Daniela STOYCHEVA (+32 2 295 36 64)
- Aikaterini APOSTOLA (+32 2 298 76 24)
Latest News from
Future-proofing the European banking market – removing the obstacles to exit21/11/2019 15:10:00
Speech by Yves Mersch, Member of the Executive Board of the ECB and Vice-Chair of the Supervisory Board of the ECB, at the S&P Global’s European Financial Institutions Conference, Paris
Autumn Fiscal Package: EC adopts Opinions on euro area Draft Budgetary Plans21/11/2019 13:20:00
The EC has presented its Opinions on euro area Member States' 2020 Draft Budgetary Plans, taken steps under the Stability and Growth Pact and adopted the fourth Enhanced Surveillance Report for Greece.
Raw materials: EC launches new online portal to support responsible sourcing in businesses21/11/2019 11:10:00
The EC has launched Due Diligence Ready!, an online portal that provides businesses with guidance on how to check the sources of the metals and minerals entering their supply chains – the so-called “due diligence” process.
More than half a million asylum applications lodged in the EU+ so far in 201921/11/2019 10:02:00
The proportion of applications receiving a positive decision (known as "recognition rate") so far this year was 34%, compared to 33% in the first nine months of 2018.
EU and the Paris agreement: towards climate neutrality20/11/2019 15:10:00
The EU will need to update its long-term climate goals in 2020. Parliament wants more ambitious goals, but will EU countries agree to aim for climate neutrality by 2050?
Oceans and seas threatened by climate change: Council adopts conclusions20/11/2019 13:20:00
The Council Hs adopted conclusions on oceans and seas, stressing that climate change is a direct and existential threat to life in oceans and seas globally.
Textiles EU's fourth largest cause of environmental pressures after food, housing, transport20/11/2019 12:10:00
Consumption of clothing, footwear and household textiles in the EU uses annually about 1.3 tonnes of raw materials and more than 100 cubic metres of water per person, according to a European Environment Agency briefing.
Chambers & Regions said a collective effort is needed to boost uptake of EU FTAs20/11/2019 11:25:00
EUROCHAMBRES and the European Committee of the Regions have conducted the joint survey over the past months, with an objective to identify opportunities and obstacles faced in the implementation of EU FTAs.
Rapid risk assessment - Sexual transmission of dengue in Spain20/11/2019 09:10:00
Spanish authorities have reported the likely sexual transmission of dengue between two men. This is the first case of dengue described in an area without the presence of vector mosquitoes that has been attributed to sexual transmission, and the first sexual transmission described between men who have sex with men (MSM).
Young migrants: Is Europe creating a lost generation?19/11/2019 16:10:00
Delays and serious challenges integrating young refugees who have fled war and persecution risk creating a lost generation, finds a new Fundamental Rights Agency (FRA) report. While it identifies some good practices, it urges Member States to learn from each other to give these young people an adequate chance in life.